Optimizing the Dosing Regimens of Daptomycin Based on the Susceptible Dose-Dependent Breakpoint against Vancomycin-Resistant Enterococci Infection

Daptomycin, a lipopeptide antibiotic, is one of the therapeutic options used for the treatment of vancomycin-resistant enterococci (VRE). Recently, the Clinical and Laboratory Standards Institute (CLSI) M100 30th edition has removed the susceptibility (S) breakpoint for Enterococcus faecium and repl...

Descripción completa

Detalles Bibliográficos
Autores principales: Santimaleeworagun, Wichai, Changpradub, Dhitiwat, Thunyaharn, Sudaluck, Hemapanpairoa, Jatapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963552/
https://www.ncbi.nlm.nih.gov/pubmed/31795437
http://dx.doi.org/10.3390/antibiotics8040245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963552/
https://www.ncbi.nlm.nih.gov/pubmed/31795437
http://dx.doi.org/10.3390/antibiotics8040245

Ejemplares similares